Press release
Global Lipid Metabolism Disease Drug Market, Size, Share, Analysis Report & Forecast to 2026
The global lipid metabolism disease drug market is estimated to grow at a CAGR of nearly XX% during the forecast period. The key factor driving the growth of the global lipid metabolism disease drug market includes the rising prevalence of lipid metabolism disorders and increasing adoption of an unhealthy lifestyle. According to the National Organizations of Rare Disorders, in 2018, lipid metabolism disorders such as Gaucher disease accounted for the 6,000 patients in the US and accounting for more than 90% of cases among Caucasians. It is a liposomal storage disorder in which due to the lack of enzyme glucocerebrosidase, certain sugars containing fats get accumulated in the body.Free Sample Copy @ https://www.omrglobal.com/request-sample/lipid-metabolism-disease-drug-market
The lipid metabolism disorders such as Gaucher disease, Niemann-Pick Disease, and Tay-Sachs disease, include lipids which are fats or fats-like substances including fatty acids, oils, waxes, and cholesterol. In this disorder, the body fails to convert fats into energy that subsequently leads to the accumulation of fats in the body which damages the various parts of the body including the liver, spleen, brain, peripheral nervous system, and many more. There are several FDA-approved drugs for the treatment of lipid metabolism disorders. For instance, Cerdelga (eliglustat) manufactured by Genzyme, was approved by the US FDA in 2014, for the long-term treatment of patients suffering from Gaucher disease. In the past few years, new drugs such as icosaapent ethyl, bempedoic acid, are being tested for the treatment of statin tolerated patients and has shown huge potential.
A Full Report of Global Lipid Metabolism Disease Drug Market is Available at:
https://www.omrglobal.com/industry-reports/lipid-metabolism-disease-drug-market
The key players contributing to the growth of the global lipid metabolism disease drug market by adopting various strategies such as product launches & developments, mergers and acquisition, partnerships, and agreements, include Merck Group, Novartis AG, Takeda Pharmaceutical, AstraZeneca, Boehringer Ingelheim, KOWA, Kythera, Fuji yakuhin, LG Life Science, Mitsubishi Tanabe Pharma among others. For instance, in 2019, Investigational New Drug (IND) application by IntraBio Inc. was approved by the US FDA for the clinical trial of IB1001-202 containing lead compound (IB1001) for the treatment of Tay-Sachs disease and Sandhoff Disease.
Global Lipid Metabolism Disease Drug Market – Segmentation
By Type
OTC
Rx Drugs
By Application
Lipoprotein disorders
Fatty acid oxidation defects
Mitochondrial disorders
Lysosomal storage disorders
Peroxisomal disorders
Purine and pyrimidine disorders
Porphyria’s
By Distribution Channel
Hospital
Retail Pharmacy
Online
Others
Global Lipid Metabolism Disease Drug Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Merck KGaA
Novartis AG
Takeda Pharmaceutical Company Ltd.
AstraZeneca Plc.
Boehringer Ingelheim
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/lipid-metabolism-disease-drug-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Lipid Metabolism Disease Drug Market, Size, Share, Analysis Report & Forecast to 2026 here
News-ID: 2418925 • Views: …
More Releases from Orion Market Research
Mobile Gamma Cameras Market Size, Shares, Business Growth and Upcoming Trends Fo …
In 2024, the global Mobile Gamma Cameras Market was valued at approximately USD 57.8 million, and it is expected to reach USD 79.2 million by 2033, reflecting a compound annual growth rate (CAGR) of around 3.39% between 2025 and 2033.
Mobile Gamma Cameras Market Overview
The Mobile Gamma Cameras Market is seeing steady growth, with demand rising across oncology, cardiology, and nuclear medicine due to its ability to provide portable,…
Dental Implants Market Set to Witness Significant Growth by 2033 | Nobel Biocare …
In 2024, the global Dental Implants Market was valued at approximately USD 6.8 billion, and it is projected to reach USD 9.8 billion by 2033, representing a compound annual growth rate (CAGR) of around 4.2% from 2025 to 2033.
Dental Implants Market Overview
The Dental Implants Market is experiencing robust growth driven by rising global incidences of tooth loss, heightened demand for aesthetic and permanent dental solutions, and rapid technological advancements-such…
Cell-based Assays Market Set to Witness Significant Growth by 2033 | Becton, Dic …
In 2024, the global Cell-based Assays Market is estimated at approximately USD 24.1 billion, and it is forecast to reach USD 45.2 billion by 2033, reflecting a compound annual growth rate (CAGR) of around 6.9% from 2025 to 2033.
Cell-based Assays Market Overview
The Cell-based Assays Market is witnessing sustained growth driven by increased demand from drug discovery, disease modeling, and safety/toxicity testing. These assays-crucial in early-stage pharmaceutical R&D-offer biologically relevant…
Business Analytics Market Set to Witness Significant Growth by 2030 | Salesforce …
In 2024, the global Business Analytics Market was valued at approximately USD 96.6 billion, and it is anticipated to expand to USD 196.5 billion by 2033, corresponding to a compound annual growth rate (CAGR) of around 7.8% between 2025 and 2033.
Business Analytics Market Overview
The Business Analytics Market is witnessing robust growth, driven by the proliferation of digital data and rising demand for real-time insights across sectors such as retail, healthcare,…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
